Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Deciphera Pharmaceuticals Inc (NQ: DCPH )

33.79 USD -0.08 (-0.24%)
Streaming Delayed Price Updated: 9:44 AM EDT, Oct 28, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 29,346
Open 33.82
Bid (Size) 33.81 (1)
Ask (Size) 34.01 (2)
Prev. Close 33.87
Today's Range 33.52 - 33.88
52wk Range 26.20 - 68.40
Shares Outstanding 58,041,410
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Deciphera Pharmaceuticals to Announce Third Quarter 2021 Financial Results and Host Conference Call and Webcast on November 2, 2021
Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) today announced that it will report its third quarter 2021 financial results on Tuesday, November 2, 2021. 
From Business Wire News Releases
Deciphera Announces Approval of QINLOCK® in Switzerland for the Treatment of Fourth-Line Gastrointestinal Stromal Tumor
Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a commercial-stage biopharmaceutical company developing innovative medicines to improve the lives of people with cancer, today announced that the Swiss... 
From Business Wire News Releases

Performance

YTD
-40.44%
-40.44%
1 Month
-0.41%
-0.41%
3 Month
+4.94%
+4.94%
6 Month
-28.82%
-28.82%
1 Year
-44.61%
-44.61%

More News

Read More
Deciphera Presents Preclinical Data from DCC-3116 Program at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
From Business Wire News Releases
Deciphera Announces Positive CHMP Opinion for QINLOCK® for the Treatment of Fourth-line Gastrointestinal Stromal Tumor
From Business Wire News Releases
Deciphera Pharmaceuticals Presents New Clinical Study Results Across Pipeline at the European Society for Medical Oncology (ESMO) Congress 2021
From Business Wire News Releases
Deciphera Pharmaceuticals to Host Virtual Investor Event Featuring Key Opinion Leaders to Discuss Rebastinib and Vimseltinib Data Presented at ESMO Congress 2021
From Business Wire News Releases
Noteworthy Wednesday Option Activity: MARA, DCPH, RIOT
Tags Stocks
From Market News Video
Deciphera Pharmaceuticals, Inc. to Present at the 19th Annual Morgan Stanley Global Healthcare Conference
From Business Wire News Releases
December 17th Options Now Available For Deciphera Pharmaceuticals (DCPH)
Tags Stocks
From Market News Video
3 Biotech Stocks With Huge Catalysts Incoming
Tags BYSI Market News ALLK
From Motley Fool
Analysts Forecast 19% Upside For ESML
Tags ETFs
From ETF Channel
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.